In the present study, we have demonstrated that VIPR1 is downregulated in HCC and that activation of VIPR1 by VIP inhibits HCC growth by regulating homeostasis of arginine metabolism and pyrimidine de novo synthesis, which are summarized in Fig. 7. This evidence concerns the gene VIP and hepatocellular carcinoma.